These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1662289)
41. A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents. O'Reilly EK; Kreuzer KN Biochemistry; 2002 Jun; 41(25):7989-97. PubMed ID: 12069589 [TBL] [Abstract][Full Text] [Related]
42. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Minford J; Pommier Y; Filipski J; Kohn KW; Kerrigan D; Mattern M; Michaels S; Schwartz R; Zwelling LA Biochemistry; 1986 Jan; 25(1):9-16. PubMed ID: 3006754 [TBL] [Abstract][Full Text] [Related]
43. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function. Per SR; Mattern MR; Mirabelli CK; Drake FH; Johnson RK; Crooke ST Mol Pharmacol; 1987 Jul; 32(1):17-25. PubMed ID: 3037302 [TBL] [Abstract][Full Text] [Related]
44. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage. De Isabella P; Zunino F; Capranico G Nucleic Acids Res; 1995 Jan; 23(2):223-9. PubMed ID: 7862525 [TBL] [Abstract][Full Text] [Related]
45. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. Tewey KM; Chen GL; Nelson EM; Liu LF J Biol Chem; 1984 Jul; 259(14):9182-7. PubMed ID: 6086625 [TBL] [Abstract][Full Text] [Related]
46. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells. Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713 [TBL] [Abstract][Full Text] [Related]
47. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA. Levac P; Moss T Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885 [TBL] [Abstract][Full Text] [Related]
48. Further characterization of an amsacrine-resistant line of HL-60 human leukemia cells and its topoisomerase II. Effects of ATP concentration, anion concentration, and the three-dimensional structure of the DNA target. Mayes J; Hinds M; Soares L; Altschuler E; Kim P; Zwelling LA Biochem Pharmacol; 1993 Aug; 46(4):699-707. PubMed ID: 8395843 [TBL] [Abstract][Full Text] [Related]
49. In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in c-myc proto-oncogene. Riou JF; Vilarem MJ; Larsen CJ; Multon E; Riou GF NCI Monogr; 1987; (4):41-7. PubMed ID: 2819730 [TBL] [Abstract][Full Text] [Related]
50. Repair of topoisomerase-mediated DNA damage in bacteriophage T4. Stohr BA; Kreuzer KN Genetics; 2001 May; 158(1):19-28. PubMed ID: 11333215 [TBL] [Abstract][Full Text] [Related]
51. In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene. Riou JF; Multon E; Vilarem MJ; Larsen CJ; Riou G Biochem Biophys Res Commun; 1986 May; 137(1):154-60. PubMed ID: 3013177 [TBL] [Abstract][Full Text] [Related]
52. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells. Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033 [TBL] [Abstract][Full Text] [Related]
53. The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei. Vilarem MJ; Riou JF; Multon E; Gras MP; Larsen CJ Biochem Pharmacol; 1986 Jul; 35(13):2087-95. PubMed ID: 3015146 [TBL] [Abstract][Full Text] [Related]
54. Application of a degenerate consensus sequence to quantify recognition sites by vertebrate DNA topoisomerase II. Spitzner JR; Muller MT J Mol Recognit; 1989 Sep; 2(2):63-74. PubMed ID: 2561527 [TBL] [Abstract][Full Text] [Related]
55. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome. Wong ML; Hsu MT J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235 [TBL] [Abstract][Full Text] [Related]
56. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903 [TBL] [Abstract][Full Text] [Related]
57. Production of protein-associated DNA breaks by 8-methoxycaffeine, caffeine and 8-chlorocaffeine in isolated nuclei from L1210 cells: comparison with those produced by topoisomerase II inhibitors. Russo P; Poggi L; Parodi S; Pedrini AM; Kohn KW; Pommier Y Carcinogenesis; 1991 Oct; 12(10):1781-90. PubMed ID: 1657426 [TBL] [Abstract][Full Text] [Related]
58. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide. Bugg BY; Danks MK; Beck WT; Suttle DP Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7654-8. PubMed ID: 1652758 [TBL] [Abstract][Full Text] [Related]
59. Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome. Benson JD; Huang ES J Virol; 1988 Dec; 62(12):4797-800. PubMed ID: 2846890 [TBL] [Abstract][Full Text] [Related]
60. Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent. Ebert SN; Shtrom SS; Muller MT J Virol; 1990 Sep; 64(9):4059-66. PubMed ID: 2166804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]